| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/27/2002 | CN1382138A Piperidine derivatives as reuptake inhibitors |
| 11/27/2002 | CN1382137A Thtrahydrothiopy 2,3-diazanaphthylaone derivatives as PDE inhibitors |
| 11/27/2002 | CN1382136A N-heterocyclic derivatives as NOS inhibitors |
| 11/27/2002 | CN1382135A Amine and amide derivatives as ligands for neuropeptide YY5 receptor usefu in treatment of obesity and other disorders |
| 11/27/2002 | CN1382134A Benzopyranyl guanidine derivtives, process for preparation thereof and pharmaceutical compositions containing them |
| 11/27/2002 | CN1382125A Bicycle vasporession agonists |
| 11/27/2002 | CN1382124A Bicycle androgen and progesterone receptor modulator compounds and methods |
| 11/27/2002 | CN1382122A Pyrrole derivatives as phosphodiesterase VII inhibitors |
| 11/27/2002 | CN1382121A C16 unsaturated FP-selective prostaglandins analogs |
| 11/27/2002 | CN1382120A Method of producing n-(4,5-bis-(methanesulfonyl)-2-methyl-benzoyl)-guanidine, hydrochloride thereof |
| 11/27/2002 | CN1382119A Substituted alpha hydroxy acid aspertate specific cysteine protease inhibitors and use thereof |
| 11/27/2002 | CN1382118A Biocyclic amino acids aspharmaceutical agents |
| 11/27/2002 | CN1382061A Pharmaceutical compositions for oral and topical administration |
| 11/27/2002 | CN1382060A Dosages for treatment with anti-ErbB2 antibodies |
| 11/27/2002 | CN1382055A Remedies |
| 11/27/2002 | CN1382054A Novel contraceptive medicament and method for producing the same |
| 11/27/2002 | CN1382053A Novel hormonal composition and use thereof |
| 11/27/2002 | CN1382052A Use of dipyridazole or mopidamol in the manufacture of a medicament for treatment and prevention of fibrin-dependent microcirculation disorders |
| 11/27/2002 | CN1382051A Injectable bupernorphine microparticle compositions and their use |
| 11/27/2002 | CN1382050A Oral formulations for anti-tumor compounds |
| 11/27/2002 | CN1382049A Method for stabilizing benzimidazole compounds |
| 11/27/2002 | CN1382048A Formulation of substituted benzimidazoles |
| 11/27/2002 | CN1382047A Neurotherapeutic clavulanate composition and method |
| 11/27/2002 | CN1382046A Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use |
| 11/27/2002 | CN1382045A Inhibitor for 20-hydroxy-eicosatetraenoic acid enzyme |
| 11/27/2002 | CN1382044A Use of cell factor inhibiting anti-inflammatory agent in rhinovirus infection |
| 11/27/2002 | CN1382043A Food materials useful in preventing and ameliorating metabolic bone diseases and preventives/remedies for metabolic bone diseases comprising these materials |
| 11/27/2002 | CN1382042A Treatment of emphysema using RAR selective retinoid agonists |
| 11/27/2002 | CN1382041A Direct comperession polymer tablet core |
| 11/27/2002 | CN1382040A Therapeutic method |
| 11/27/2002 | CN1382039A Liposome formulation of 6,9-bis-[(2-aminoethyl)-amino]benzo[g]isoquinoline-5, 10-dione dimaleate |
| 11/27/2002 | CN1382038A New and improved formulation for paclitaxel |
| 11/27/2002 | CN1382037A Oral solution containing galanthamine and sweetening agent |
| 11/27/2002 | CN1382036A Solubilized pharmaceutical composition for parenteral administration |
| 11/27/2002 | CN1382022A Method for treatment of chronic venous insufficiencies using extract of red vine leaves |
| 11/27/2002 | CN1381512A Multi-arm fork type functional polyethylene glycol preparation method and its application in medicine |
| 11/27/2002 | CN1381464A Antineoplastic compound intercedenside A |
| 11/27/2002 | CN1381463A Magnesium isoglycyrrhetate and its preparing process and usage |
| 11/27/2002 | CN1381459A Deacidified gingko leaf and its extract and its preparing process and application |
| 11/27/2002 | CN1381456A Pyrimidine-4-keto compound, its preparation method and medicine composition containing them |
| 11/27/2002 | CN1381455A Method for synthe sizing (3aS)-5, 5-dioxo-2, 3, 3a, 4-tetrahydric-1H-pyrrolo [2,1-c] [1,2,4] benzodiazine |
| 11/27/2002 | CN1381449A Aralkylone pipeazine derivative and its application |
| 11/27/2002 | CN1381448A Aralkylformylalkyl piperazine derivative and its application as brain nerve protector |
| 11/27/2002 | CN1381257A Chinese-medicinal antihypertensive pillow |
| 11/27/2002 | CN1381255A Compoiste bear gall spray for treating rhinocleisis and its preparing process |
| 11/27/2002 | CN1381237A Extract for treating cardiovascular and cerebrovascular diseases |
| 11/27/2002 | CN1381236A Medicinal composition containing baicalin and caffoeoylchinic acid |
| 11/27/2002 | CN1381235A Baokang capsule as natural health-care product |
| 11/27/2002 | CN1381234A Application of toosendanin as inducer to make differentiation and death of tumor cells |
| 11/27/2002 | CN1381233A Solid disperser of quick-releasing vitamine A acid |
| 11/27/2002 | CN1381174A Two-component and three-component fungicide compound |
| 11/27/2002 | CN1094977C Polysaccharides having high iduronic acid content |
| 11/27/2002 | CN1094943C Urethanes and ureas that induce cytokine production |
| 11/27/2002 | CN1094942C Propiophenone derivatives and process for preparing the same |
| 11/27/2002 | CN1094937C Farnesyltransferase inhibiting quinazolinones |
| 11/27/2002 | CN1094936C New flavnoe compounds, process for preparing them and pharmaceutical compositions containing them |
| 11/27/2002 | CN1094931C Antithrombotic organic nitrates |
| 11/27/2002 | CN1094930C Quinoxaline and preparation method and application thereof |
| 11/27/2002 | CN1094929C Acetamide derivatives, process for producing the same, and medicinal composition containing the same |
| 11/27/2002 | CN1094926C Antimer pure acetacetates, its preparation method and use |
| 11/27/2002 | CN1094765C External-use burn ointment |
| 11/27/2002 | CN1094760C Double-layered buccal tablet of Chinese globeflower and vitamin C and its making process |
| 11/27/2002 | CN1094758C Modulation of calcium channels |
| 11/27/2002 | CN1094757C Isobutyl gamma-amino-butyric acid and its derivatives for treatment of pain |
| 11/27/2002 | CN1094756C Combined antipyretic analgesic drug |
| 11/27/2002 | CN1094755C Controlled release agent containing reamine benzene ring alcohol or it salt |
| 11/27/2002 | CN1094754C Cell renewal rate compositions |
| 11/27/2002 | CN1094734C Method for preparing fatty acid ester and nutriment containing fatty acid ester |
| 11/26/2002 | US6486349 Amide therapeutics and methods for treating inflammatory bowel disease |
| 11/26/2002 | US6486342 Substituted chiral allosteric hemoglobin modifiers |
| 11/26/2002 | US6486329 Amorphous form of cell cycle inhibitor having improved solubility and bioavailability |
| 11/26/2002 | US6486326 iso-CBI and iso-CI analogs of CC-1065 duocarmycins |
| 11/26/2002 | US6486325 Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds |
| 11/26/2002 | US6486324 Forming libraries of bactericides; immobilization; side effect reduction |
| 11/26/2002 | US6486322 Azaindole derivatives, process for their preparation, and their use as antitumor agents |
| 11/26/2002 | US6486321 Epoxidation; quaternization |
| 11/26/2002 | US6486318 Single pot process for preparing metal picolinates from alpha picoline |
| 11/26/2002 | US6486315 Recrystallization processes |
| 11/26/2002 | US6486305 Method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 11/26/2002 | US6486299 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity |
| 11/26/2002 | US6486287 Such as n,n-bis(2-trimethoxysilylpropyl)ethanolamine; for silanation of surfaces such as glass and subsequent immobilization of nucleic acids and polypeptides |
| 11/26/2002 | US6486286 Use of hexahydrolupulones as antibacterial agents |
| 11/26/2002 | US6486214 Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby |
| 11/26/2002 | US6486212 Semifluorinated alkanes and the use thereof |
| 11/26/2002 | US6486211 Indole compounds |
| 11/26/2002 | US6486210 Such as enantiomorphs of 4-fluorostyryl-2,3,4,5,6-pentafluorobenzylsulfone; antiproliferative/anticancer agents |
| 11/26/2002 | US6486209 Use for 1,3-propanediol derivatives |
| 11/26/2002 | US6486208 Sustained release, and comfortable opthalmic composition and method for ocular therapy |
| 11/26/2002 | US6486207 Compositions and methods for amelioration of human female sexual dysfunction |
| 11/26/2002 | US6486206 Mechanical and pharmacologic therapies to treat cardiac arrest |
| 11/26/2002 | US6486205 Mixture of primary fatty acids obtained from sugar cane wax |
| 11/26/2002 | US6486204 Treatment or prevention of prostate cancer with a COX-2 selective inhibiting drug |
| 11/26/2002 | US6486203 Treating inflammatory diseases of the head and neck with cyclooxygenase-2 inhibitors |
| 11/26/2002 | US6486201 Agarofuan derivatives, their preparation, pharmaceutical composition containing them and their use as medicine |
| 11/26/2002 | US6486200 Prodrugs for antimicrobial amidines |
| 11/26/2002 | US6486199 Spiro and dispiro 1,2,4-trioxolane antimalarials |
| 11/26/2002 | US6486198 Compounds and methods for the treatment of post traumatic stress disorder |
| 11/26/2002 | US6486194 Alzheimer's disease |
| 11/26/2002 | US6486192 Indole compounds useful for treating bacterial infections |
| 11/26/2002 | US6486190 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability |